We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Forms Molecular Imaging Unit

By HospiMedica staff writers
Posted on 28 Jun 2005
Siemens Medical Solutions (Erlangen, Germany)has announced that it has formed a new division called Siemens Medical Solutions Molecular Imaging, which combines its nuclear medicine operations with CTI Molecular Imaging, Inc. More...
(Culver City, CA, USA), a leading developer of positron emission tomography (PET) imaging equipment and services.

CTI is a wholly owned subsidiary of Siemens Medical Solutions, acquired by Siemens in May 2005 in a transaction valued at around U.S.$1 billion. With this acquisition and the formation of a division centered on PET and single photon emission computed tomography (SPECT)-based molecular imaging technologies, Siemens strengthens its dedication to molecular imaging development, technologic innovation, and the creation of dynamic new technologies that will update the diagnosis and treatment of disease. This includes the development and distribution of molecular biomarkers, preclinical imaging for research and pharmaceuticals, and application and post-processing for molecular imaging.

"Uniting Siemens Nuclear Medicine with CTI to form a new molecular
imaging division supports our vision to be the innovation trendsetter
in the healthcare industry,” said Erich Reinhardt, Ph.D., president and CEO, Siemens Medical Solutions.

"CTI and Siemens are two pioneering companies in the healthcare technology field,” said Ronald Nutt, Ph.D., founder and former president and CEO of CTI Molecular Imaging, who is now the chief scientific advisor of the new Siemens division. "This new partnership marks an exciting step in our quest to discover and pursue new paths in molecular medicine, and reflects our overall strategy to personalize healthcare and positively impact the way illness is identified and treated.”





Related Links:
Siemens Medical Solutions
CTI Molecular Imaging

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Pediatric Mask
Respire SOFT
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.